Oncocyte Announces Executive Leadership Changes; Says Ronnie Andrews Will Step Down As Chief Executive Officer, Director Of Co.’s Board Effective Dec. 1, 2022, Joshua Riggs To Serve As Interim CEO
Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey, today
